---
title: "Glycomimetics (GLYC.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/GLYC.US.md"
symbol: "GLYC.US"
name: "Glycomimetics"
industry: "Biotechnology"
datetime: "2026-04-14T23:25:12.555Z"
locales:
  - [en](https://longbridge.com/en/quote/GLYC.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/GLYC.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/GLYC.US.md)
---

# Glycomimetics (GLYC.US)

## Company Overview

GlycoMimetics, Inc. engages in the discovery and development of therapies for cancers and inflammatory diseases in the United States. The company was founded in 2003 and is based in Monrovia, Maryland.

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Exchange | US Market |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.34 | 136 | - | - | - |
| PB | 3.00 | 312 | 3.00 | 3.00 | 3.00 |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/GLYC.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/GLYC.US/norm.md)
- [Related News](https://longbridge.com/en/quote/GLYC.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/GLYC.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**